; (B) the format and content of data submissions to the Secretary under this section; (C) the format of electronic submissions to the Secretary under this section; (D) consolidated proceedings and the procedures for such proceedings where appropriate; and (E) for minor changes in drugs, recommendations on how to comply with the requirements in administrative orders issued under subsection (c)(3). (l) Electronic format All submissions under this section shall be in an electronic format specified by the Secretary after providing a period for public comment. (m) Inapplicability of Paperwork Reduction Act Chapter 35 of title 44, United States Code, shall not apply to collections of information made under this section. . 102. Misbranding Section 502 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 352 ) is amended by inserting after subsection (dd) the following: (ee) If it is a nonprescription drug that is not the subject of an application approved under section 505, and does not comply with the requirements under section 505G. (ff) If it is a drug for which fees under section 744L–1 have been assessed but have not been paid. . 103. Conforming amendments to the Sunscreen Innovation Act (a) Review of nonprescription ingredients subject to Sunscreen Innovation Act (1) Pending sunscreen ingredients Nonprescription sunscreen active ingredients or combinations of sunscreen active ingredients subject, on the date of enactment of this Act, to a proposed sunscreen order, as defined in section 586(7) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 360fff(7) ), shall— (A) continue to be reviewed in accordance with section 586C of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 360fff–3 )